FMO2 and breast cancer: A new high-throughput drug metabolizing enzymes and transporters microarray platform revealed that single nucleotide polymorphism in FMO2 was significantly associated with docetaxel-induced febrile neutropenia in Lebanese breast cancer patients [31].